Wall Street Zen cut shares of Quantum-Si (NASDAQ:QSI – Free Report) from a hold rating to a sell rating in a research note published on Saturday,Wall Street Zen reports.
QSI has been the topic of a number of other reports. HC Wainwright restated a “buy” rating and issued a $4.00 price target on shares of Quantum-Si in a research note on Tuesday, September 29th. Alliance Global Partners reiterated a “buy” rating on shares of Quantum-Si in a research report on Friday, August 14th. Finally, Weiss Ratings raised Quantum-Si from a “sell (e+)” rating to a “sell (d-)” rating in a report on Thursday, September 24th. Two analysts have rated the stock with a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $2.50.
Quantum-Si Stock Up 8.4%
Quantum-Si (NASDAQ:QSI – Get Free Report) last posted its earnings results on Thursday, August 13th. The company reported ($0.11) EPS for the quarter, hitting analysts’ consensus estimates of ($0.11). The business had revenue of $0.34 million during the quarter, compared to the consensus estimate of $0.30 million. Quantum-Si had a negative net margin of 6,138.26% and a negative return on equity of 47.12%. Sell-side analysts expect that Quantum-Si will post -0.47 EPS for the current fiscal year.
Hedge Funds Weigh In On Quantum-Si
Several large investors have recently made changes to their positions in QSI. Renaissance Technologies LLC bought a new position in Quantum-Si during the first quarter valued at $91,000. WINTON GROUP Ltd bought a new stake in shares of Quantum-Si in the 2nd quarter worth about $67,000. Green Alpha Advisors LLC bought a new stake in shares of Quantum-Si in the 2nd quarter worth about $41,000. Corient Private Wealth LP purchased a new position in shares of Quantum-Si during the 2nd quarter worth about $34,000. Finally, IPG Investment Advisors LLC purchased a new position in shares of Quantum-Si during the 2nd quarter worth about $27,000. 39.90% of the stock is currently owned by hedge funds and other institutional investors.
Quantum-Si Company Profile
Quantum-Si Incorporated (NASDAQ:QSI) is a life sciences technology company focused on advancing proteomics, the study of proteins and their roles in biological systems. The company develops tools intended to help researchers identify and analyze proteins at the single-molecule level, supporting applications in drug discovery, translational research and precision medicine.
Its primary offering is the Platinum platform, which combines an automated instrument, proprietary sequencing technology, consumables and software for protein analysis.
Further Reading
- Five stocks we like better than Quantum-Si
- Carnival and CarMax Pop on Strong Earnings, but Challenges Remain
- 3 Income Stocks Under $30 That Yield More Than the 10-Year Treasury Note
- 3 AI Winners, 3 Very Different Paths to Higher Margins
- Plexus Is Booming—But Can the Growth Story Last?
Receive News & Ratings for Quantum-Si Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quantum-Si and related companies with MarketBeat.com's FREE daily email newsletter.
